NEC、企業や官公庁の基幹業務を支えるプラットフォーム製品群を強化

ENGLISH
|
JAPANESE
|
CONNECT WITH US:

2016年09月12日 10時20分

Source: NEC Corporation

NEC、企業や官公庁の基幹業務を支えるプラットフォーム製品群を強化

東京, 2016年09月12日 - (JCN Newswire) - NECは、企業や官公庁の基幹業務を支えるプラットフォーム製品群の強化として、最新CPUを採用し高性能化と高信頼性を実現したエンタープライズサーバ「NX7700xシリーズ」の新製品5機種と、業務アプリケーションの開発・保守の効率化を支援する「SystemDirector Enterprise」の機能強化を実施し、本日より販売を開始します。

NECは社会ソリューション事業に注力しており、オープンな技術を活用した「NX7700xシリーズ」の強化に加え、メインフレーム「ACOSシリーズ」の強化やサポートを継続提供することで、幅広く進化する基幹システムに対するニーズに応え、社会インフラの高度化と安心で安全な利用を支援します。

本リリースの詳細は下記URLをご参照ください。
http://jpn.nec.com/press/201609/20160912_01.html

概要：日本電気株式会社（NEC)

詳細は www.nec.co.jp をご覧ください。

本件に関するお客様からのお問い合わせ先
NX7700xシリーズお問い合わせ窓口
E-Mail: contact@nx7700x.jp.nec.com

SystemDirector Enterpriseお問合せ窓口
http://jpn.nec.com/SystemDirectorEnterprise/contact.html

Source: NEC Corporation
セクター: メディア, IT

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Latest Release

Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST

NaaS Technology Inc.

NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST

Honda Motor Co, Ltd

Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST

Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST

Lexaria Bioscience

ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST

Mitsubishi Heavy Industries, Ltd.

Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST

Eisai

Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST

Eisai

Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST

Kingsoft Corporation Limited

Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST

Olympus

NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST

Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST

CleverTap

CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 18, 2024 23:30 JST

NEC Corporation

World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
Nov 18, 2024 17:29 JST

Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business
Nov 18, 2024 12:31 JST

Toyota Motor Corporation

Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round
Nov 18, 2024 09:25 JST

COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding
Nov 16, 2024 18:00 JST

Mitsubishi Heavy Industries, Ltd.

Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki
Nov 15, 2024 18:58 JST

Eisai

Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)
Nov 15, 2024 17:33 JST

Eisai

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
Nov 15, 2024 14:31 JST

Mitsubishi Corporation

Resorttrust Group and Mitsubishi Corporation Launch Joint Study in Medical Tourism
Nov 15, 2024 12:32 JST

More Latest Release >>